Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(33%)
Results Posted
100%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
2
33%
Ph phase_2
2
33%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Active, not recruiting2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (50.0%)
N/A2 (50.0%)

Trials by Status

completed117%
terminated117%
unknown233%
active_not_recruiting233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
RADIATION
Total Trials
6